Abstract
All cell types from the testis can give rise to neoplasms. It is of relevance to distinguish germ cell tumors and nongerm cell tumors. Understanding the existence of the various types of neoplasms of the testis, and getting insight into their pathogenesis, requires knowledge about the normal anatomy and physiology of both the developing and mature testis. The germ cell tumors represent the most frequent neoplasm, followed by the sex cord–stromal tumors (Leydig cell and Sertoli cell tumors) and others. Based on morphological criteria, germ cell tumors are subdivided into seminoma, embryonal carcinoma, yolk sac tumor, teratoma, choriocarcinoma, and spermatocytic tumor. Alternatively, a classification system has been proposed, in which age at presentation, pattern of genomic imprinting, cell of origin, chromosomal constitution, as well as representative animal model(s) are included. Within the testis, three of these subtypes can be found, each with their own clinical and pathological characteristics. Based on this recognition, an informative set of diagnostic markers has been developed, proven to be of value in a clinical setting. These can even be applied for early diagnosis, i.e., in the preinvasive stage, in specific groups of individuals known to be at risk. This will possibly prevent the need for systemic treatment, irradiation, or chemotherapy at a relatively young age, known to have significant side effects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Suggested Reading
Almstrup K, Lobo J, Mørup N, et al. Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours. Nat Rev Urol. 2020;17:201–13.
Al-Obaidy KI, Chovanec M, Cheng L. Molecular characteristics of testicular germ cell tumors: pathogenesis and mechanisms of therapy resistance. Expert Rev Anticancer Ther. 2020;20:75–9.
Berney DM, Cree I, Rao V, et al. An introduction to the WHO 5th edition 2022 classification of testicular tumours. Histopathology. 2022;81:459–66.
Cheng L, Sung MT, Cossu-Rocca P, et al. LHJ: OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol. 2007;211:1–9.
Cheng L, Lyu B, Roth LM. Perspectives on testicular germ cell neoplasms. Hum Pathol. 2017;59:10–25.
Cheng L, Albers P, Berney DM, et al. Testicular Cancer. Nat Rev Dis Primers. 2018;4:29.
Cheng L, MacLennan GT, Bostwick DG, editors. Urologic surgical pathology. 4th ed. Philadelphia, PA: Elsevier; 2020.
Cheng L, Davidson DD, Montironi R, et al. Fluorescence in situ hybridization (FISH) detection of chromosomal 12p anomalies in testicular germ cell yumors. Methods Mol Biol. 2021a;2195:49–63.
Cheng L, Mann SA, Lopez-Beltran A, et al. Molecular characterization of testicular germ cell tumors using tissue microdissection. Methods Mol Biol. 2021b;2195:31–47.
Chovanec M, Cheng L. Molecular characterization of testicular germ cell tumors: chasing the underlying pathways. Future Oncol. 2019;15:227–9.
Chovanec M, Cheng L. Advances in diagnosis and treatment of testicular cancer. BMJ. 2022;379:e070499.
Emerson RE, Cheng L. Premalignancy of the testis and paratestis. Pathology. 2013;45:264–72.
Heijnsdijk EAM, Supit SJ, Looijenga LHJ, et al. Screening for cancers with a good prognosis: the case of testicular germ cell cancer. Cancer Med. 2021;10:2897–903.
King J, Adra N, Einhorn LH. Testicular cancer: biology to bedside. Cancer Res. 2021;81:5369–76.
Kozakova K, Mego M, Cheng L, et al. Promising novel therapies for relapsed and refractory testicular germ cell tumors. Expert Rev Anticancer Ther. 2021;21:53–69.
LeĂ£o R, Albersen M, Looijenga LHJ, et al. Circulating MicroRNAs, the next-generation serum biomarkers in testicular germ cell tumours: a systematic review. Eur Urol. 2021;80:456–66.
Lobo J, Gillis AJM, van den Berg A, et al. Identification and validation model for informative liquid biopsy-based microRNA biomarkers: insights from germ cell tumor in vitro, in vivo and patient-derived data. Cells. 2019;8:1637.
Lobo J, van Zogchel LMJ, Nuru MG, et al. Combining hypermethylated RASSF1A detection using ddPCR with miR-371a-3p testing: an improved panel of liquid biopsy biomarkers for testicular germ cell tumor patients. Cancers (Basel). 2021;13:5228.
Looijenga LH. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights. J Pathol. 2009;218:146–62.
Looijenga LHJ, van der Kwast TH, Grignon D, et al. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: IV: Current and Future Utilization of Molecular-Genetic Tests for Testicular Germ Cell Tumors. Am J Surg Pathol. 2020;44:e66–79.
Mohanty SK, Lobo A, Cheng L. The 2022 revision of the World Health Organization classification of tumors of the urinary system and male genital organs: advances and challenges. Hum Pathol. 2023;136:123–43.
Oosterhuis JW, Looijenga LH. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer. 2005;5:210–22.
Oosterhuis JW, Looijenga LHJ. Human germ cell tumours from a developmental perspective. Nat Rev Cancer. 2019;19:522–37.
Roth LM, Cheng L. Mixed germ cell-sex cord stromal tumor of the testis with an intratubular component: a problem in differential diagnosis. Hum Pathol. 2016;51:51–6.
Roth LM, Cheng L. On the histogenesis of mixed germ cell-sex cord stromal tumour of the gonads. J Clin Pathol. 2017;70:22–227.
Roth LM, Cheng L. Gonadoblastoma: origin and outcome. Hum Pathol. 2020;100:47–53.
Roth LM, Lyu B, Cheng L. Perspectives on testicular sex cord-stromal tumors and those composed of both germ cells and sex cord-stromal derivatives with a comparison to corresponding ovarian neoplasms. Hum Pathol. 2017;65:1–14.
Shen H, Shih J, Hollern DP, et al. Integrated molecular characterization of testicular germ cell tumors. Cell Rep. 2018;23:3392–406.
Timmerman DM, Remmers TL, Hillenius S, Looijenga LHJ. Mechanisms of TP53 pathway inactivation in embryonic and somatic cells-relevance for understanding (Germ Cell) tumorigenesis. Int J Mol Sci. 2021a;22:5377.
Timmerman DM, Gillis AJM, Mego M, Looijenga LHJ. Comparative analyses of liquid-biopsy microRNA371a-3p isolation protocols for serum and plasma. Cancers (Basel). 2021b;13:4260.
Timmerman DM, Eleveld TF, Sriram S, et al. Chromosome 3p25.3 gain is associated with cisplatin resistance and is an independent predictor of poor outcome in male malignant germ cell tumors. J Clin Oncol. 2022;40:3077–87.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Biermann, K., Cheng, L., Looijenga, L.H.J. (2023). Molecular Pathology of Testicular Cancer. In: Cheng, L., Netto, G.J., Eble, J.N. (eds) Molecular Surgical Pathology. Springer, Cham. https://doi.org/10.1007/978-3-031-35118-1_16
Download citation
DOI: https://doi.org/10.1007/978-3-031-35118-1_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-35117-4
Online ISBN: 978-3-031-35118-1
eBook Packages: MedicineMedicine (R0)